Exagen Inc. (XGN)

Exagen Revenue

Exagen had revenue of $15.06M in the quarter ending June 30, 2024, with 6.56% growth. This brings the company's revenue in the last twelve months to $56.66M, up 7.05% year-over-year. In the year 2023, Exagen had annual revenue of $52.55M with 15.33% growth.

• Revenue (ttm): $56.66M
• Revenue Growth: +7.05%
• P/S Ratio: 0.80
• Revenue / Employee: $316,536
• Employees: 179
• Market Cap: 45.20M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	52.55M	6.99M	15.33%
Dec 31, 2022	45.56M	-2.74M	-5.66%
Dec 31, 2021	48.30M	6.32M	15.07%
Dec 31, 2020	41.98M	1.59M	3.93%
Dec 31, 2019	40.39M	7.95M	24.50%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.